Tuesday, October 23, 2018
Redactor's Choice
You are here: Home / Tag: therapy

Tag: therapy

First patient treated with high energy proton therapy in UK

22_proteusone_ambient_wildflower_xraybooth (1)

The first patient in the UK has been treated with high energy proton beam therapy at Proton Partners’ new Rutherford Cancer Centre in Newport, South Wales. It’s the first oncology clinic in the UK to provide high energy proton beam therapy for targeted tumor treatments. Proton Partners International has partnered with IBA (Ion Beam Applications), a leading provider of proton therapy solutions and Philips, a global leader in health technology. To plan patient treatment the solution integrates Philips’ Big Bore CT and Pinnacle3 Treatment ... Read More »

Art & Meditation Workshops with Chad Love Lieberman

Europe

Dr. Chad Love Lieberman explains the fundamental aspects of his periodic workshops for therapists and enthusiast. Mr. Chad "Love" Lieberman is a renowned art therapist who has been practicing art therapy for more than 20 years. He recently convened a session to announce that he will be offering art and meditation workshops wherein interested attendees could learn how to leverage art therapies for personal growth as well as to deal with any other inner conflicts that affect their quality of life. "Our aim as a practice through these worksh... Read More »

CHMP recommends EU approval of Roche’s Gazyvaro™ for people with chronic lymphocytic leukemia

medical

“We are delighted the CHMP has recognized the strength of the Gazyvaro data established in the CLL11 study,” said Sandra Horning, M.D., Roche’s Chief Medical Officer and Head, Global Product Development. “Typically, around half of patients diagnosed with CLL have comorbidities that make full-dose fludarabine based treatment unsuitable for them. We are pleased to be one step closer to making Gazyvaro available as a new foundation of treatment for their disease.” The CHMP opinion is based primarily on data from the phase III CLL11 study that w... Read More »

Campground-themed X-Ray adventure series first in South Carolina region

rengen

The staff at the new clinic is catered to pediatric after-hour care needs when their pediatrician’s office may be closed. A small clinic setting, as opposed to a large hospital, is often appealing to parents of frightened children. All equipment is sized specifically for children. The Cozy Camp Adventure Series gives children the chance to be scanned in a specialized sleeping bag an impressive camp setting. The Adventure X-ray room starts with a Bear Brook Adventure coloring book that’s given to child when an X-ray is needed. The coloring book ... Read More »

Roche to present new data on 27 different medicines at ASCO

meeting

“Since the first ASCO annual meeting 50 years ago, we are proud to have contributed practice-changing advances for people with a broad range of tumors including breast, blood, colorectal, lung, and skin cancers,” said Sandra Horning, Chief Medical Officer and Head, Global Product Development. “Data from 9 approved and 18 investigational medicines, such as our anti-PDL1 immunotherapy, at ASCO this year demonstrate our continued commitment to improve outcomes for people with cancer.” The data to be presented at ASCO show the depth and strength of... Read More »

Pfizer’s Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food and Drug Administration Breakthrough Therapy Designation for Potential Prevention of Meningococcal B Disease

medicine

Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pfizer’s vaccine candidate, bivalent rLP2086, currently under investigation for the prevention of invasive meningococcal disease due to Neisseria meningitidis serogroup B in persons 10 – 25 years of age. Disease caused by Neisseria meningitidis serogroup B has been estimated at between 20,000 and 80,000 cases per year globally, and can result in death or significant long-term disabilities, including brain damage ... Read More »

Hokkaido University and Hitachi complete a facility incorporating a novel proton beam therapy system for cancer treatment

heart2

The FIRST Program is a major research support structure established as part of a Japanese government initiative to promote science and technology. At a meeting of the Council for Science and Technology Policy in March 2010, out of a total of 565 applications from across Japan, 30 "Core Researchers and Projects" were awarded grants based on their notable potential in the advancement of Japanese science and technology. Hokkaido University's "Advanced Radiation Therapy Project Real-time Tumor-tracking with Molecular Imaging Technique" project was ... Read More »

Depression in Pregnancy: New study shows preferences for therapy over medication

pregnant

The preliminary study, led by Cynthia L. Battle, PHD, of the Warren Alpert Medical School of Brown University, Butler Hospital, and Women & Infants' Hospital of Rhode Island, helps to fill the gap in knowledge about women's preferences and decision-making patterns regarding treatment for depression during and after pregnancy. Women Discuss Preferences and Concerns Regarding Treatment for Perinatal Depression The researchers performed in-depth interviews with 61 pregnant women at 32 weeks' gestation. Participants were a subset of wome... Read More »

ExAblate receives extended CE Mark Certification for benign and cancerous bone tumors

hospital23

InSightec Ltd, the leader in MRI guided Focused Ultrasound therapy, has announced that its ExAblate(R) systems have received an extended European CE Mark for the local treatment of cancerous and benign primary and secondary bone tumors, including but not limited to multiple myeloma, bone metastases, osteoid osteoma as well as facet joint back pain, The CE mark applies to the ExAblate 2000 and 2100 as well as the ExAblate 2100 Conformal Bone System. The CE mark was based on additional published clinical evidence. ExAblate combines therapeutic a... Read More »

Scroll To Top